Dr Kymberley Vickery

Biography

Previous roles include:

• Australian Institute for Commercialisation, a division of Queensland Manufacturing Institute, Senior Commercialisation Consultant (July2011-June 2013).  This role involved the initiation and management of innovation and collaboration services that assist organisations to grow, working with entrepreneurs, businesses, research organisations and governments in converting intellectual property (IP)  into successful business outcomes.  Recent contracts include:
• Provision of commercialisation and IP advisory services to the Gold Coast Health Services District covering all disciplines, eg oncology, haematology, immunology, pre-clinical trailing, nursing and allied health (0.4 FTE).
• IP advisory and project management services to IP Australia to reconfigure the Australian patent examiner training program for use in ASEAN and African developing nations
• Development and delivery of a Transition Plan from a CRC structure into a self-sustaining organisation (http://www.cieam.com/blog/2011/12/14/transition-to-cieam-iii); and
• Delivery of an early commercialisation plan to the QLD Reconstruction Authority (http://www.qldreconstruction.org.au/about/darmsys).
• Delivery of IP Awareness Workshops for Queensland government employees (Client: Dept of Science, Information Technology, Innovation and the Arts)

SCIENTIFIC INTELLECTUAL PROPERTY CONSULTING (ScIP), QLD FOUNDER AND PRINCIPAL   (2005–) http://www.scipconsulting.com)   ScIP has provided independent advisory, management, business development and qualified commercialisation services to the general technology and life science areas. Some recent clients include:

• Bond University, QLD

Providing scientific research and IP contract management and policy advisory services in relation to US government bio-forensics research contracts

• The University of Queensland

Provision of critical reviews of research grant applications in applied science, biotechnology and nanotechnology.

• The University of New South Wales

Facilitator, workshop to develop and evaluate an implementation model for the NHMRC Partnership Project on Implementing Guidelines for Preventive Care in General Practice, a collaboration of the Heart Foundation, RACGP and BUPA Foundation with UNSW, Bond, Flinders and Monash Universities.

• Julius Kruttschnitt Mineral Research Centre, The University of Queensland

Preparation of mineral based innovation Research Partnership Program funds application for collaboration with key industrial leader for a tailored 3D platform for the characterization of ore samples containing precious metals, base metals and for minerals in coals.

• AUSTRALIAN FUTURE FORENSIC INNOVATION NETWORK Ltd (AFFIN)

Executive Officer AFFIN, a $7M independent national NFP organisation with some 19 partners in the research organisation, police, forensic practitioners and policy sectors; The EO role encompassed all project management of the organisation’s 7 R&D Programs, their individual contract negotiation, inclusive of IP and licensing aspects, reporting to government and partners, development of new organisational business plan (approved by government and key stakeholders); Provision of board papers and reporting direct to the AFFIN Board. Provision of commercialisation advice to AFFIN’s 13thCooperative Research Centre (CRC) Round Application and advice on incorporation processes.

• BIOSCIENCE APPLICATIONS Pty Ltd, Victoria

Providing commercialisation services for product distribution of newly-developed scientific equipment in the Asia-Pacific region.

• Ramsden Bow Lawyers, Gold  Coast  QLD

Providing life science patent drafting expertise; consultant to Patent team.

• VENTUREPRO Pty Ltd,  Associate Director (2008-2010) Assisted multi-collaboration research teams develop R&D business cases for capital raising.  Examples include:
• Negotiated and secured a nine party police, practitioner and university NIRAP Research Collaborative Agreement (2009) in 90 days;
• Provided commercialisation expertise to 13th Round CRC Forensics Bid (Griffith University);
• Co-writer of NIRAP awarded to Griffith University $2M (2009);
• RIPP awarded to Bond University – Chronic Fatigue Syndrome $533K (2009); and
• Team writer NIRAP awarded to University of QLD – Aviation Fuel Initiative $2M (2010)

• NANOMICS BIOSYSTEMS PTY LTD, QLD Project Director         (2006- Sept2008) $2.1M QLD Smart State RIPP “Biosecurity Program” - commercialisation and prototype development of animal and plant pathogen-based diagnostics; recruited and managed small team (15) in two locations.   IP Manager   (2005-Sept2008);  Chief Executive Officer and (de facto) Director     (Jul2006 –Dec2007)

•  IMAGINOT PTY LTD, Princess Alexandria Hospital, QLD IP Manager       (2005) Provided company patent strategy advice with reference to competitor’s portfolio Liaised with in-house inventors and researchers, international patent counsel and attorneys for patent landscaping and prosecution purposes Prepared successful prosecution arguments to IP Australia

• Centre for Nanotechnology & Biomaterials, The University of Queensland            Business Development Manager     (2005–2007)

•  Centre for Companion Animal Health, Veterinary School, The University of Qld  Centre Research Manager     (2005)

• Fisher Adams Kelly, Patent & Trade Mark Attorneys, Brisbane      (2003-2004) Registered Patent and Trade Marks Attorney, Chemical and Biotechnology Groups

Worked closely with local technology-based clients, largely university researchers, to provide: drafting and prosecution services and advice, assignments, infringement and FTO opinions and related services for SME’s, agribusinesses,  pharmaceutical and university clients

• Baldwin Shelston Waters, Patent Attorneys, Sydney, NSW                  (2001-2002) Patent Technical Assistant, Alchemist Intellectual Property Team

Assisted in prosecution of national phase applications in Australia and New Zealand Initiated Trans-Tasman Advisory Regulatory Service advising on chemical regulatory matters

• National Occupational Health & Safety Commission, Sydney, NSW       (1999-2001) Chemical Regulatory Assessment Officer

Provided regulatory evaluation of new commercially sensitive industrial chemicals Coordinated departmental quarterly business plans and budgets for the NOHSC annual report Previous Research Roles:   Macquarie University, Sydney, NSW Honorary Associate, School of Chemistry   (1999-2004) Postdoctoral Research Fellow, Lecturer/Tutor, School of Chemistry (1998-1999) Designed, prepared and delivered, postgraduate course in Biomedicinal Chemistry Authored 20+ primary peer-reviewed international research publications

•   Chalmers University of Technology, Goteborg, Sweden  (1998) Postdoctoral Research Fellow,  Department of Physical Chemistry Swedish Institute Guest Researcher Award, allowing postdoctoral research in any chosen Swedish institution; administered by the Dept. Foreign Affairs, Sweden. Research Project “Novel 3D molecular probes for nucleic acids using chiral-spectroscopic and high-field NMR methods” Supervisor: Professor Bengt Nordén, Chair, Nobel Committee for Chemistry & Medicine.

• Macquarie University, Sydney, NSW                                                              (1993-1997)Australian Research Council PhD Scholar (Bioinorganic Chemistry) Thesis: “Molecular Recognition Between DNA and Chiral Intercalative Metalloprobes” Dean’s Commendation: Awarded in recognition of a PhD thesis of exceptionally high standard.  Nominated for the 1998 RACI Cornforth Medal.  

• The University of Sydney, Department of Surgery, NSW                           (1992-1993)Senior Technical Research Officer Joint role with Department of Urology (Royal Prince Alfred Hospital, Sydney) and Genetic Toxicology Unit (NIOH&S). Project title: “Development of secondary colonic carcinomas (post-operative) and the role of urinary carcinogens”.

• The University of Sydney, School of Chemistry, NSW                             (1991) Honours Research Program Honours Thesis “Stereospecific Platinum Complexes Used as Biological Probes”

• RESEARCH OUTPUT

Research Publications: Refereed articles  

1. Preparation, Characterisation, Cytotoxicity, and Mutagenicity of a Pair of Enantiomeric Platinum(II) Complexes with the Potential to Bind Enantioselectively to DNA, Vickery, K., Bonin, A., Fenton, R., O’Mara, S., Russel, P., Webster, L. and Hambley, T., J.  Medicinal Chemistry, (1993), 36, 3663-3668.
2. The Development of DNA-Immobilised Chromatographic Stationary Phases for Optical Resolution and DNA-Affinity Comparison of Metal Complexes, J.R.Aldrich-Wright, I. Greguric, R.S. Vagg, K.A. Vickery and P.A. Williams. J. Chromatography A, (1995) 718, 436-443.
3. Use of the Ames Test to Provide Structural Information on DNA Binding, K.A. Vickery.Computer Design and Automation News, Molecular Graphics and Modelling Society, Nov.-Dec., (1995), 13-14.
4. Molecular Recognition Between DNA and Chiral Intercalative Metalloprobes, K.A. Vickery, A.M. Bonin, R.S. Vagg and P.A. Williams, J. Biomolecular Structure and Dynamics, (1997), 14, 802-803.
5. D-cis-a-[Ru(RR-picchxnMe2)(phen)]2+ Shows Minor Groove AT Selectivity with Oligonucleotides. E.M. Proudfoot, P.H. Karuso, J.P. Mackay, R.S. Vagg, K.A. Vickery and P.A. Williams. J. Chemical Society, Chemical Communications, (1997), 1623-1624.
6. Development of Ruthenium Probes Designed to Bind Enantio- and Stereospecifically to DNA, R.S. Vagg, K.A. Vickery and P.A. Williams, Molecular Recognition and Inclusion, (A.W. Coleman Ed.), Kluwer Academic Publishers, Dordrecht, (1998), 239-244.
7. Molecular Recognition Between DNA and Chiral Intercalative Metalloprobes, K.A. Vickery,Proceedings of the Royal Society of New South Wales, (1998), 131, 121-122.
8. DNA Binding of Some Chiral Metallointercalators Derived from 9,10-Phenanthrenediamine, S.F. Murphy-Poulton, R.S. Vagg, K.A. Vickery and P.A. Williams,Metal-Based Drugs, (1998) 5, 225-231.
9. Molecular Recognition Between DNA and Chiral Intercalative Metalloprobes, K.A. Vickery, A.M. Bonin, R.S. Vagg and P.A. Williams, Structure, Motion, Interaction and Expression of Biological Macromolecules, (R.H. Sarma and M.H. Sarma Eds.), Adenine Press, New York, (1998), 1, 195-206.
10. Electronic Spectroscopy: Induced Circular Dichroism, K.A. Vickery and B. Nordén, inApplications Encyclopedia of Spectroscopy & Spectrometry, (J. Lindon, G. Tanter and J. Holmes Eds), Academic Press, 869-874 (1999).
11. L and D-cis-b-[Ru(RR-picchxn)(phen)]2+ Metalloprobes Show Differential Binding Geometries with d(CGCGATCGCG)2, M.E. Eriksson and K.A. Vickery (Abstracted in theRACI and Inorganic Specialist Group Meeting of The New Zealand Institute of Chemistry, Victoria University of Wellington, New Zealand (1998), L19.
12. Linear Dichroism Analysis of Some Ternary Ru(II) Metallointercalators of DNA, P. Lincoln, B. Nordén, R.S. Vagg, P.A. Williams and K.A. Vickery. Abstracted in the XXXIII International Conference on Coordination Chemistry, Firenze, Italy, (1998), 325.
13. DNA Binding of L- and D-cis-b-[Ru(RR-picchxn)(phen)]2+ Studied by NMR and Flow Linear Dichroism Spectroscopy, K.A. Vickery, R.S. Vagg, P. Lincoln, B. Nordén and M.E. Eriksson, J. Biomolecular Structure and Dynamics, 17, No. 3, 519-525, (1999).
14. The Preparation, Characterisation, and DNA Adduct Profile of 2-amino-2-methyl-3-butanoneoximedichloroplatinum(II), a Platinum(II) Complex Designed to Bind to GpA Sequences of DNA, Ling E.C.H., Allen G.W., Vickery, K. and Hambley, T.W, J. Inorganic Biochemistry, 78(1), 55-62 (2000).

International Research Conference Papers  

1. Using Drug Design to Probe the Interaction Between Platinum Anti-cancer Drugs and DNA. T.W. Hambley, G.W. Allen, H. Meng Er, R.R. Fenton, E.C.H. Ling & K.A. Patser, Asian Crystallographic Association, Singapore (1992), 16B-2. (Please note: Vickery née Patser)
2. Biological Activity of Some Ru(II) Complexes Designed to Bind Enantio- and Stereospecifically to DNA.  K.A.Vickery, J.R.A-Wright, A. Bonin, P.H. Karuso, R.S.Vagg and P.A.Williams. Abstracts of the Third International Symposium on Applied Bioinorganic Chemistry, Fremantle, Western Australia, (1994), B8-9.
3. DNA-Immobilised Chromatographic Stationary Phases for Optical Resolution and DNA-Affinity Comparison of Metal Complexes. J.R.A-Wright, I. Greguric, P. Leverett, R.S. Vagg, K.A. Vickery and P.A. Williams. Abstracts of the Third International Symposium on Applied Bioinorganic Chemistry, Fremantle, Western Australia, (1994), A14.
4. Structural Studies of Ruthenium Complexes Which Intercalate With Oligonucleotides. K.A. Durkin, P.H. Karuso, R.S.Vagg, E.M. Proudfoot, R.S. Vagg, K.A. Vickery and P.A. Williams. Abstracts of the Third International Symposium on Applied Bioinorganic Chemistry, Fremantle, Western Australia, (1994), B6.
5. Molecular Recognition of DNA by Chiral Multidentate Metal Complexes  J.R.A-Wright, P.H. Karuso, S.E. Kidd, E.M. Proudfoot, D.L. Sutherland, R.S. Vagg, K.A. Vickery and P.A. Williams. Abstracts of the Third International Symposium on Applied Bioinorganic Chemistry, Fremantle, Western Australia, (1994), A25.
6. Development of Ruthenium Probes Designed to Bind Enantio- and Stereospecifically to DNA, K.A. Vickery, A.M. Bonin, P.H. Karuso, P.A. Williams and R.S.Vagg, 9th International Symposium on Molecular Recognition and Inclusion, Ecole Normale Suprieure de Lyon, Lyon, France, (1996).
7. Linear Dichroism Analysis of Some Ternary Ru(II) Metallointercalators, K. Vickery, P. Williams, R. Vagg, P. Lincoln and B. Nordén, Abstracts of the XXXIII International Conference on Coordination Chemistry, Firenze, Italy, (1998), 325.
8. Molecular Recognition Between Nucleic Acids and Some Chiral Ternary Metallointercalators, K.A. Vickery, R.S. Vagg, B. Nordén and P.A. Willams, Xth International Symposium on Molecular Recognition and Inclusion, Warsaw, Poland (1998), L-11.
9. DNA Binding of Some Chiral Metallointercalators Derived from 9,10-Phenanthrenediamine, S.F. Murphy-Poulton, R.S. Vagg, K.A. Vickery and P.A. Williams,IXth International. Conference on the Coordination and Organometallic Chemistry of Germanium, Tin and Lead, Metals in Medicine Workshop, Melbourne, Sept. (1998), P3.
10. L and D-cis-b-[Ru(RR-picchxn)(phen)]2+ Metalloprobes show Differential Binding Geometries with d(CGCGATCGCG)2, M.E. Eriksson and K.A. Vickery, Inorganic Division of RACI and Inorganic Specialist Group of The New Zealand Institute of Chemistry, Conference Abstracts, Victoria University of Wellington, New Zealand, (1999), L19.
11. DNA Binding of L- and D-cis-b-[Ru(RR-picchxn)(phen)]2+ as Probed by NMR and Flow Linear Dichroism Spectroscopy, K.A. Vickery R. S. Vagg, P. Lincoln, B. Nordén and M.E. Eriksson, 11th Conversation in the Discipline of Biomolecular Stereodynamics, The University, Albany, New York; abstracted in J. Biomolecular Structure and Dynamics, (1999), 16, 1339-1340.